Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are anti-obesity drugs that were recently shown to be effective in reducing body weight and ameliorating cardiovascular outcomes in patients with overweight or obesity [51]. This evidence concerns the gene GCG and obesity disorder.